The FDA has approved Cobenfy, the first new schizophrenia medication in over 30 years, offering a novel treatment approach for managing symptoms like hallucinations and delusions.

The FTC has filed a lawsuit against the largest U.S. pharmacy benefit managers, accusing them of artificially raising insulin prices and increasing costs for patients.

New research links weekend sleep catch-up with a 20% reduced risk of heart disease, suggesting that compensating for lost sleep could offer significant health benefits.

South Korea’s latest data shows a rapid increase in COVID-19 levels in wastewater, reflecting a larger summer outbreak.

Rising MPox cases in Italy and Korea, and anticipated cases in France, drive heightened alertness and preventive measures.

Researchers have raised concerns about erythritol, suggesting the sweetener could significantly boost the risk of cardiovascular diseases.